KindredBio     Print Page | Close Window

Investor Overview

KindredBio is focused on bringing breakthrough human products and innovative new technologies to veterinary medicine to address unmet clinical needs and provide benefits to animal co... 

Stock Information

NASDAQ CM$9.34
Change (%) + 0.52 (5.90%)
Volume130,541
Data as of 04/25/19 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.

NEWS

Kindred Biosciences to Announce First Quarter 2019 Financial Results

April 25, 2019

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences Announces Fourth Quarter and Full Year 2018 Financial Results

March 6, 2019

SAN FRANCISCO, March 6, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences to Announce Fourth Quarter and Year-End 2018 Financial Results

February 19, 2019

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...